Charles Bennett to Warfarin
This is a "connection" page, showing publications Charles Bennett has written about Warfarin.
Connection Strength
0.782
-
Will newer anticoagulants improve therapy persistence? Arch Intern Med. 2012 Nov 26; 172(21):1689-90.
Score: 0.392
-
Underreporting of hemorrhagic and thrombotic complications of pharmaceuticals to the U.S. Food and Drug Administration: empirical findings for warfarin, clopidogrel, ticlopidine, and thalidomide from the Southern Network on Adverse Reactions (SONAR). Semin Thromb Hemost. 2012 Nov; 38(8):905-7.
Score: 0.390